{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:05:48Z","timestamp":1788897948889,"version":"build-2803163510"},"reference-count":62,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["CP2_10\/2018"],"award-info":[{"award-number":["CP2_10\/2018"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["AIFA-2016-02364896"],"award-info":[{"award-number":["AIFA-2016-02364896"]}]},{"name":"Ricerca indipendente AIFA","award":["CP2_10\/2018"],"award-info":[{"award-number":["CP2_10\/2018"]}]},{"name":"Ricerca indipendente AIFA","award":["AIFA-2016-02364896"],"award-info":[{"award-number":["AIFA-2016-02364896"]}]},{"name":"Italian Ministry of Health\u2014Ricerca Corrente IRCCS","award":["CP2_10\/2018"],"award-info":[{"award-number":["CP2_10\/2018"]}]},{"name":"Italian Ministry of Health\u2014Ricerca Corrente IRCCS","award":["AIFA-2016-02364896"],"award-info":[{"award-number":["AIFA-2016-02364896"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background Recently, mesenchymal stromal cells (MSCs) have gained recognition for their clinical utility in transplantation to induce tolerance and to improve\/replace pharmacological immunosuppression. Cord blood (CB)-derived MSCs are particularly attractive for their immunological naivety and peculiar anti-inflammatory and anti-apoptotic properties. Objectives: The objective of this study was to obtain an inventory of CB MSCs able to support large-scale advanced therapy medicinal product (ATMP)-based clinical trials. Study design: We isolated MSCs by plastic adherence in a GMP-compliant culture system. We established a well-characterized master cell bank and expanded a working cell bank to generate batches of finished MSC(CB) products certified for clinical use. The MSC(CB) produced by our facility was used in approved clinical trials or for therapeutic use, following single-patient authorization as an immune-suppressant agent. Results: We show the feasibility of a well-defined MSC manufacturing process and describe the main indications for which the MSCs were employed. We delve into a regulatory framework governing advanced therapy medicinal products (ATMPs), emphasizing the need of stringent quality control and safety assessments. From March 2012 to June 2023, 263 of our Good Manufacturing Practice (GMP)-certified MSC(CB) preparations were administered as ATMPs in 40 subjects affected by Graft-vs.-Host Disease, nephrotic syndrome, or bronco-pulmonary dysplasia of the newborn. There was no infusion-related adverse event. No patient experienced any grade toxicity. Encouraging preliminary outcome results were reported. Clinical response was registered in the majority of patients treated under therapeutic use authorization. Conclusions: Our 10 years of experience with MSC(CB) described here provides valuable insights into the use of this innovative cell product in immune-mediated diseases.<\/jats:p>","DOI":"10.3390\/cells13121066","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:47:17Z","timestamp":1718797637000},"page":"1066","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical Use"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-5347","authenticated-orcid":false,"given":"Tiziana","family":"Montemurro","sequence":"first","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-6167","authenticated-orcid":false,"given":"Cristiana","family":"Lavazza","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-2695","authenticated-orcid":false,"given":"Elisa","family":"Montelatici","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-1307","authenticated-orcid":false,"given":"Silvia","family":"Budelli","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5709-3956","authenticated-orcid":false,"given":"Salvatore","family":"La Rosa","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-897X","authenticated-orcid":false,"given":"Mario","family":"Barilani","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-4557","authenticated-orcid":false,"given":"Cecilia","family":"Mei","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-2708","authenticated-orcid":false,"given":"Paolo","family":"Manzini","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1193-1197","authenticated-orcid":false,"given":"Ilaria","family":"Ratti","sequence":"additional","affiliation":[{"name":"Milano Cord Blood Bank and Center of Transfusion Medicine, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6309-8880","authenticated-orcid":false,"given":"Silvia","family":"Cimoni","sequence":"additional","affiliation":[{"name":"Milano Cord Blood Bank and Center of Transfusion Medicine, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9192-8028","authenticated-orcid":false,"given":"Manuela","family":"Brasca","sequence":"additional","affiliation":[{"name":"Milano Cord Blood Bank and Center of Transfusion Medicine, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Prati","sequence":"additional","affiliation":[{"name":"Milano Cord Blood Bank and Center of Transfusion Medicine, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-6117","authenticated-orcid":false,"given":"Giorgia","family":"Saporiti","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Cellular Therapy Center, Hematology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-5218","authenticated-orcid":false,"given":"Giuseppe","family":"Astori","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Cellular Therapies and Haematology Unit, San Bortolo Hospital, AULSS8 \u201cBerica\u201d, 36100 Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-0064","authenticated-orcid":false,"given":"Francesca","family":"Elice","sequence":"additional","affiliation":[{"name":"Laboratory of Advanced Cellular Therapies and Haematology Unit, San Bortolo Hospital, AULSS8 \u201cBerica\u201d, 36100 Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-0752","authenticated-orcid":false,"given":"Rosaria","family":"Giordano","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9434-4538","authenticated-orcid":false,"given":"Lorenza","family":"Lazzari","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Gene Therapy, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"ref_1","first-page":"393","article-title":"The Development of Fibroblast Colonies in Monolayer Cultures of Guinea-Pig Bone Marrow and Spleen Cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/jpsu.2001.27945","article-title":"The Amniotic Fluid as a Source of Cells for Fetal Tissue Engineering","volume":"36","author":"Kaviani","year":"2001","journal-title":"J. Pediatr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13625","DOI":"10.1073\/pnas.240309797","article-title":"Postnatal Human Dental Pulp Stem Cells (DPSCs) in Vitro and in Vivo","volume":"97","author":"Gronthos","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14653240410005366-1","article-title":"Isolation and Characterization of Mesenchymal Progenitor Cells from Chorionic Villi of Human Placenta","volume":"6","author":"Igura","year":"2004","journal-title":"Cytotherapy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","article-title":"Mesenchymal Progenitor Cells in Human Umbilical Cord Blood","volume":"109","author":"Erices","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"McElreavey, K.D., Irvine, A.I., Ennis, K.T., and McLean, W.H.I. (1991). Isolation, Culture and Characterisation of Fibroblast-like Cells Derived from the Wharton\u2019s Jelly Portion of Human Umbilical Cord. Biochem. Soc. Trans., 19.","DOI":"10.1042\/bst019029s"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/stem.2541","article-title":"Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells","volume":"35","author":"Jaimes","year":"2017","journal-title":"Stem Cells"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1537-2995.2001.41050606.x","article-title":"Outcomes of a Program to Evaluate Mother and Baby 6 Months after Umbilical Cord Blood Donation","volume":"41","author":"Lecchi","year":"2001","journal-title":"Transfusion"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"618243","DOI":"10.3389\/fimmu.2020.618243","article-title":"Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation","volume":"11","author":"Remuzzi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic Cell Transplantation and Cellular Therapy Survey of the EBMT: Monitoring of Activities and Trends over 30 Years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"570282","DOI":"10.3389\/fped.2020.570282","article-title":"Umbilical Cord Blood Transplants: Current Status and Evolving Therapies","volume":"8","author":"Gupta","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_13","unstructured":"(2023, May 11). WMDA Total Number of Donors and Cord Blood Units. Available online: https:\/\/statistics.wmda.info\/."},{"key":"ref_14","unstructured":"(2023, May 11). HCT Presentation Slides. Available online: https:\/\/bethematchclinical.org\/medical-education-and-research\/hct-presentation-slides\/#\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-4939-3584-0_14","article-title":"Isolation, Culture, and Characterization of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells","volume":"1416","author":"Bieback","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejcb.2016.04.003","article-title":"Angiogenic and Anti-Inflammatory Properties of Mesenchymal Stem Cells from Cord Blood: Soluble Factors and Extracellular Vesicles for Cell Regeneration","volume":"95","author":"Montemurro","year":"2016","journal-title":"Eur. J. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","article-title":"Comparison of Molecular Profiles of Human Mesenchymal Stem Cells Derived from Bone Marrow, Umbilical Cord Blood, Placenta and Adipose Tissue","volume":"37","author":"Heo","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","article-title":"Comparative Characteristics of Mesenchymal Stem Cells from Human Bone Marrow, Adipose Tissue, and Umbilical Cord Blood","volume":"33","author":"Wagner","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fimmu.2018.02013","article-title":"Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges","volume":"9","author":"Peltzer","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15420","DOI":"10.1038\/s41598-019-51937-9","article-title":"Central Metabolism of Functionally Heterogeneous Mesenchymal Stromal Cells","volume":"9","author":"Barilani","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/scd.2014.0160","article-title":"Dissection of the Cord Blood Stromal Component Reveals Predictive Parameters for Culture Outcome","volume":"24","author":"Barilani","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_22","unstructured":"(2023, May 11). Standards|FACT. Available online: https:\/\/factglobal.org\/standards\/."},{"key":"ref_23","unstructured":"(2023, May 11). Ministero della Salute Disposizioni Relative Ai Requisiti Di Qualit\u00e0 e Sicurezza Del Sangue e Degli Emocomponenti. Available online: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2015\/12\/28\/15A09709\/sg."},{"key":"ref_24","first-page":"4825","article-title":"How We Make Cell Therapy in Italy","volume":"9","author":"Montemurro","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_25","unstructured":"(2023, May 12). European Medicines Agency Re-Establishment of Working Seeds and Working Cell Banks Using TSE Compliant Materials\u2014Scientific Guideline. Available online: https:\/\/www.ema.europa.eu\/en\/re-establishment-working-seeds-working-cell-banks-using-tse-compliant-materials-scientific-guideline."},{"key":"ref_26","unstructured":"(2023, May 12). European Medicines Agency Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products\u2014Scientific Guideline. Available online: https:\/\/www.ema.europa.eu\/en\/minimising-risk-transmitting-animal-spongiform-encephalopathy-agents-human-veterinary-medicinal."},{"key":"ref_27","unstructured":"Cavani, S., Camurri, L., Giardino, D., Romana Grati, F., Bernardini, L., Angioni, A., Battaglia, P., Calzone, R., Cardarelli, L., and Carella, M. (2024, May 14). Societ\u00e0 Italiana Di Genetica Umana Gruppo Di Lavoro in Citogenetica SIGU LINEE GUIDA PER LA DIAGNOSI CITOGENETICA 2013 a Cura Del Gruppo Di Lavoro in Citogenetica SIGU Hanno Preso Parte Alla Stesura: Coordinatore: Antonio Novelli Revisione Del Testo: Bruno Dallapiccola. Available online: https:\/\/sigu.net\/wp-content\/uploads\/2020\/11\/Linee_Guida_14_febbraio-2014.pdf."},{"key":"ref_28","first-page":"3038565","article-title":"Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production","volume":"2018","author":"Budelli","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cherubini, A., Rusconi, F., and Lazzari, L. (2021). Identification of the Best Housekeeping Gene for RT-QPCR Analysis of Human Pancreatic Organoids. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260902"},{"key":"ref_30","unstructured":"(2024, May 14). Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on Advanced Therapy Medicinal Products and Amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004 (Text with EEA Relevance). Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32007R1394."},{"key":"ref_31","unstructured":"(2024, May 14). Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. Available online: https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2001:311:0067:0128:en:PDF."},{"key":"ref_32","unstructured":"(2023, May 12). Ministero della Salute Disposizioni in Materia Di Medicinali per Terapie Avanzate Preparati Base Non Ripetitiva. (15A01704) (GU n.56 Del 9-3-2015). Available online: https:\/\/www.gazzettaufficiale.it\/atto\/stampa\/serie_generale\/originario."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s13287-022-03112-7","article-title":"First Clinical Application of Cord Blood Mesenchymal Stromal Cells in Children with Multi-Drug Resistant Nephrotic Syndrome","volume":"13","author":"Morello","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41409-020-01199-1","article-title":"Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee","volume":"56","author":"Sharma","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review","volume":"52","author":"Caplan","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhou, L., and Yao, S. (2023). Recent Advances in Therapeutic CRISPR-Cas9 Genome Editing: Mechanisms and Applications. Mol. Biomed., 4.","DOI":"10.1186\/s43556-023-00115-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.97.7.3213","article-title":"Rapid Expansion of Recycling Stem Cells in Cultures of Plastic-Adherent Cells from Human Bone Marrow","volume":"97","author":"Colter","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/scd.2006.0660","article-title":"Identification of Cord Blood-Derived Mesenchymal Stem\/Stromal Cell Populations with Distinct Growth Kinetics, Differentiation Potentials, and Gene Expression Profiles","volume":"16","author":"Markov","year":"2007","journal-title":"Stem Cells Dev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous HMSCs Improve Myocardial Infarction in Mice Because Cells Embolized in Lung Are Activated to Secrete the Anti-Inflammatory Protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells","volume":"36","author":"Luk","year":"2018","journal-title":"Stem Cells"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eaam7828","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in Mesenchymal Stromal Cells Induces in Vivo Recipient-Mediated Immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hemonc.2013.02.002","article-title":"Parameters That Influence the Isolation of Multipotent Mesenchymal Stromal Cells from Human Umbilical Cord Blood","volume":"6","author":"Vasaghi","year":"2013","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcyt.2015.10.001","article-title":"Evaluation of a Cell-Banking Strategy for the Production of Clinical Grade Mesenchymal Stromal Cells from Wharton\u2019s Jelly","volume":"18","author":"Coca","year":"2016","journal-title":"Cytotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/sctm.19-0022","article-title":"Banking Mesenchymal Stromal Cells from Umbilical Cord Tissue: Large Sample Size Analysis Reveals Consistency Between Donors","volume":"8","author":"Raileanu","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sypecka, M., Bzinkowska, A., Sulejczak, D., Dabrowski, F., and Sarnowska, A. (2022). Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem\/Stromal Cells Derived from Wharton\u2019s Jelly. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010652"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cryobiol.2022.08.002","article-title":"Optimisation of Processing Methods to Improve Success in the Derivation of Human Multipotent Mesenchymal Stromal Cells from Cryopreserved Umbilical Cord Tissue Fragments","volume":"108","author":"Vives","year":"2022","journal-title":"Cryobiology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1182\/blood-2011-01-330514","article-title":"Hematopoietic Stem\/Progenitor Cells, Generation of Induced Pluripotent Stem Cells, and Isolation of Endothelial Progenitors from 21- to 23.5-Year Cryopreserved Cord Blood","volume":"117","author":"Broxmeyer","year":"2011","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0237086100","article-title":"High-Efficiency Recovery of Functional Hematopoietic Progenitor and Stem Cells from Human Cord Blood Cryopreserved for 15 Years","volume":"100","author":"Broxmeyer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mojsilovi\u0107, S., Jaukovi\u0107, A., Kukolj, T., Obradovi\u0107, H., \u00d0ordevi\u0107, I.O., Petrovi\u0107, A., and Bugarski, D. (2021). Tumorigenic Aspects of MSC Senescence-Implication in Cancer Development and Therapy. J. Pers. Med., 11.","DOI":"10.3390\/jpm11111133"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression","volume":"5","author":"Desprez","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/jcp.30638","article-title":"Age-Related Changes in the Energy of Human Mesenchymal Stem Cells","volume":"237","author":"Barilani","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Barilani, M., Cherubini, A., Peli, V., Polveraccio, F., Bollati, V., Guffanti, F., Del Gobbo, A., Lavazza, C., Giovanelli, S., and Elvassore, N. (2020). A Circular RNA Map for Human Induced Pluripotent Stem Cells of Foetal Origin. EBioMedicine, 57.","DOI":"10.1016\/j.ebiom.2020.102848"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcyt.2013.11.004","article-title":"Evaluation of Human Platelet Lysate versus Fetal Bovine Serum for Culture of Mesenchymal Stromal Cells","volume":"16","author":"Hemeda","year":"2014","journal-title":"Cytotherapy"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ratushnyy, A., Ezdakova, M., and Buravkova, L. (2020). Secretome of Senescent Adipose-Derived Mesenchymal Stem Cells Negatively Regulates Angiogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051802"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1111\/jcmm.16817","article-title":"Mesenchymal Stem Cells from Different Sources Show Distinct Therapeutic Effects in Hyperoxia-Induced Bronchopulmonary Dysplasia in Rats","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/scd.2014.0327","article-title":"Heterogeneous Functions of Perinatal Mesenchymal Stromal Cells Require a Preselection before Their Banking for Clinical Use","volume":"24","author":"Peltzer","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4252\/wjsc.v15.i4.105","article-title":"Banking of Perinatal Mesenchymal Stem\/Stromal Cells for Stem Cell-Based Personalized Medicine over Lifetime: Matters Arising","volume":"15","author":"Li","year":"2023","journal-title":"World J. Stem Cells"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sanabria-de la Torre, R., Qui\u00f1ones-Vico, M.I., Fern\u00e1ndez-Gonz\u00e1lez, A., S\u00e1nchez-D\u00edaz, M., Montero-V\u00edlchez, T., Sierra-S\u00e1nchez, \u00c1., and Arias-Santiago, S. (2021). Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132991"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1039\/C9TB02309G","article-title":"Surface Modification of Polymeric Electrospun Scaffolds via a Potent and High-Affinity Integrin A4\u03b21 Ligand Improved the Adhesion, Spreading and Survival of Human Chorionic Villus-Derived Mesenchymal Stem Cells: A New Insight for Fetal Tissue Engineering","volume":"8","author":"Hao","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1634\/stemcells.2006-0467","article-title":"Tissue Transglutaminase Is Essential for Integrin-Mediated Survival of Bone Marrow-Derived Mesenchymal Stem Cells","volume":"25","author":"Song","year":"2007","journal-title":"Stem Cells"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/15419061.2013.876012","article-title":"Contribution of the A8 Integrin Chain to the Expression of Extracellular Matrix Components","volume":"21","author":"Volkert","year":"2014","journal-title":"Cell Commun. Adhes."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/12\/1066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:01:13Z","timestamp":1760108473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/12\/1066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["cells13121066"],"URL":"https:\/\/doi.org\/10.3390\/cells13121066","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]}}}